Reaktionsgleichung
[N:1]#[C:2][NH2:3].BrN1C(=[O:10])CCC1=O.[CH3:12][O:13][C:14]1[C:28]([S:29][CH3:30])=[C:27]([C:31]([F:34])([F:33])[F:32])[CH:26]=[CH:25][C:15]=1[C:16]([NH:18][C:19]1[N:23]([CH3:24])[N:22]=[N:21][N:20]=1)=[O:17].CC(C)([O-])C.[K+].O.[Mn]([O-])(=O)(=O)=O.[Na+].S(=O)(=O)(O)[O-].[Na+]>CO.O>[C:2]([N:3]=[S:29]([C:28]1[C:14]([O:13][CH3:12])=[C:15]([CH:25]=[CH:26][C:27]=1[C:31]([F:32])([F:34])[F:33])[C:16]([NH:18][C:19]1[N:23]([CH3:24])[N:22]=[N:21][N:20]=1)=[O:17])[CH3:30])#[N:1].[C:2]([N:3]=[S:29]([C:28]1[C:14]([O:13][CH3:12])=[C:15]([CH:25]=[CH:26][C:27]=1[C:31]([F:33])([F:34])[F:32])[C:16]([NH:18][C:19]1[N:23]([CH3:24])[N:22]=[N:21][N:20]=1)=[O:17])([CH3:30])=[O:10])#[N:1]Komponenten
Edukt 6
Produkt 2
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
At RT, 234 mg (5.56 mmol) of cyanamide and 1.06 g (5.96 mmol) of N-bromosuccinimide were added in succession to a solution of 1.14 g (3.27 mmol) of 2-methoxy-3-(methylsulfanyl)-N-(1-methyl-1H-tetrazol-5-yl)-4-(trifluoromethyl)benzamide and 440 mg (3.92 mmol) of potassium tert-butoxide in 70 ml of methanol. The contents were then stirred at RT for 16 h. For work-up, the mixture was freed from the solvent on a rotary evaporator at a temperature of at most 30° C. The residue was stirred in a mixture of 150 ml of ice-cold dichloromethane and 50 ml of ice-cold aqueous 10% by weight strength sodium bisulfate solution for about two minutes. After phase separation, the aqueous phase was extracted with 50 ml of dichloromethane. On a rotary evaporator, the combined organic phases were freed from the solvent. The residue was taken up in 60 ml of acetonitrile and 60 ml of water. 1.57 g (9.80 mmol) of sodium permanganate monohydrate were then added. The reaction mixture was stirred at RT for four days. For work-up, aqueous 10% by weight strength sodium bisulfate solution was added. Water was then added, and the mixture was extracted three times with dichloromethane. On a rotary evaporator, the combined organic phases were freed from the solvent at a temperature of at most 30° C. The residue was purified chromatographically, which gave 40 mg of 3-(N-cyano-S-methylsulfinimidoyl)-2-methoxy-N-(1-methyl-1H-tetrazol-5-yl)-4-(trifluoromethyl)benzamide and 650 mg of 3-(N-cyano-S-methylsulfonimidoyl)-2-methoxy-N-(1-methyl-1H-tetrazol-5-yl)-4-(trifluoromethyl)benzamide.
Aufarbeitung
- customFor work-up, the mixture was freed from the solvent on a rotary evaporator at a temperature of at most 30° C
- stirringThe residue was stirred in a mixture of 150 ml of ice-cold dichloromethane and 50 ml of ice-cold aqueous 10% by weight strength sodium bisulfate solution for about two minutes
- customAfter phase separation
- extractionthe aqueous phase was extracted with 50 ml of dichloromethane
- customOn a rotary evaporator
- stirringThe reaction mixture was stirred at RT for four days
- extractionthe mixture was extracted three times with dichloromethane
- customOn a rotary evaporator
- customwere freed from the solvent at a temperature of at most 30° C
- customThe residue was purified chromatographically
Quellen und Nachweise
- ORD-Eintrag
- ord-57f46a2cf8b64ab2908d72254c341c93
- Quelldatensatz
- uspto-grants-2015_10
- Patentnummer
- US09167819B2
Verknüpfte Notizen
Wird geladen…